glyburide has been researched along with Supranuclear Palsy, Progressive in 1 studies
Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
Supranuclear Palsy, Progressive: A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Brain samples from five patients with Huntington's disease were studied." | 1.29 | Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease. ( Agid, Y; De Paermentier, F; Holemans, S; Javoy-Agid, F; Laterre, EC; Maloteaux, JM, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holemans, S | 1 |
| Javoy-Agid, F | 1 |
| Agid, Y | 1 |
| De Paermentier, F | 1 |
| Laterre, EC | 1 |
| Maloteaux, JM | 1 |
1 other study available for glyburide and Supranuclear Palsy, Progressive
| Article | Year |
|---|---|
Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease.
Topics: Adenosine Triphosphate; Aged; Aged, 80 and over; Animals; ATP-Binding Cassette Transporters; Brain C | 1994 |